Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end‐diastolic umbilical artery flow: international multicenter cohort study
Ultrasound in Obstetrics & Gynecology · 2025-07 · 66 (1) · 41-50
DOI: 10.1002/uog.29241 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 29.05.2025. Verfasst von A T R Noll und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Fetal Therapy, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Umbilical Arteries, Pregnancy, Twin, Pregnancy Reduction, Multifetal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LUMC Global, Stichting Jo Kolk Studiefonds, Center for Innovative Medicine.
Abstract (Originalsprache)
Objectives
Monochorionic diamniotic (MCDA) twins with selective fetal growth restriction (sFGR) and either continuous (cAREDF) or intermittent (iAREDF) absent or reversed end‐diastolic flow in the umbilical artery face significant fetal and neonatal risks. This study evaluated fetal and neonatal outcomes in these cases and compared outcomes for the larger twin following selective reduction (SR) vs expectant management (EM).
Methods
This was an international retrospective cohort study of MCDA twin pregnancies with sFGR and cAREDF or iAREDF from five fetal medicine centers over 7 years (2016–2022). Patients were included based on an estimated fetal weight (EFW) discordance of ≥ 20% combined with cAREDF or iAREDF. We collected demographic and antenatal characteristics, longitudinal ultrasound and management data, and key perinatal outcomes, including gestational age (GA) at birth, survival rate and severe neonatal morbidity. Outcomes for the larger twin following SR vs EM were compared using logistic regression with standardization, inverse probability weighting and augmented inverse probability weighting to adjust for confounders. Average treatment effects (risk differences) were calculated for three composite outcomes (live birth at ≥ 32 weeks; live birth at ≥ 32 weeks and absence of severe neonatal morbidity; and live birth without a GA limit and absence of severe neonatal morbidity) and overall live birth.
Results
Data were analyzed from 363 MCDA twin pregnancies (726 fetuses) with sFGR, which were diagnosed initially as having either cAREDF ( n = 124) or iAREDF ( n = 239). The umbilical artery flow pattern changed in 59% of pregnancies during gestation. Smaller twins with cAREDF at the final ultrasound scan before demise, delivery or intervention had a 70% survival rate, with 29% of survivors experiencing severe neonatal morbidity. In contrast, larger twins in this group had an 87% survival rate and a 26% risk of severe neonatal morbidity among survivors. For smaller twins with iAREDF at the final ultrasound scan, the survival rate was 83% and 22% of survivors were affected by severe neonatal morbidity, whereas larger twins had an 87% survival rate and a 13% risk of severe neonatal morbidity among survivors. The combined risk of adverse outcomes (fetal or neonatal demise or severe neonatal morbidity) was 52% for smaller twins with cAREDF and 37% for those with iAREDF. Among 37 cases of spontaneous fetal demise, 24 (65%) were double demise. Severe cerebral injury following single fetal demise occurred in approximately 30% of survivors. SR was associated with a 32–34% higher probability of the larger twin being liveborn ≥ 32 weeks compared with EM. This benefit seemed to align with later GA at birth and reduced rate of severe neonatal morbidity, despite similar rates of live birth.
Conclusions
MCDA twins with sFGR and cAREDF or iAREDF are at high risk for demise and severe morbidity, particularly the smaller twin with cAREDF. Compared with EM, SR significantly improves the chance of the larger twin being born at ≥ 32 weeks and surviving without severe morbidity, which may be influenced by increased GA at birth. These data should inform patient counseling and management decisions. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Fetal Therapy, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
- Center for Fetal Medicine, Pregnancy Care and Delivery, Karolinska University Hospital, Stockholm, Sweden.
- Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Ontario Fetal Centre, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
- Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.
- Fetal Medicine Research Center, BCNatal, Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain.
ORCID-Profile: A T R Noll, K Nulens, T Van Mieghem, S Shinar, L Lewi
Förderung
- LUMC Global
- Stichting Jo Kolk Studiefonds
- Center for Innovative Medicine
- Fonds Wetenschappelijk Onderzoek
- Center for Innovative Medicine, Johns Hopkins University
Zitieren
APA
Noll, A. T. R., van Hoogstraten, A., Nulens, K., van Geloven, N., Van Mieghem, T., Shinar, S., Zuazagoitia, P. A., Bennasar, M., Russo, F. M., Tiblad, E., Herling, L., Lewi, L., Joanne Verweij, E. J. T., & ALIGN Study Group (2025). Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end‐diastolic umbilical artery flow: international multicenter cohort study. Ultrasound in Obstetrics & Gynecology, 66(1), 41-50. https://doi.org/10.1002/uog.29241
Vancouver
Noll ATR, van Hoogstraten A, Nulens K, van Geloven N, Van Mieghem T, Shinar S, et al. Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end‐diastolic umbilical artery flow: international multicenter cohort study. Ultrasound in Obstetrics & Gynecology. 2025;66(1):41-50. doi:10.1002/uog.29241
BibTeX
@article{Noll2025,
author = {Noll, A T R and van Hoogstraten, A and Nulens, K and van Geloven, N and Van Mieghem, T and Shinar, S and Zuazagoitia, P A and Bennasar, M and Russo, F M and Tiblad, E and Herling, L and Lewi, L and Joanne Verweij, E J T and ALIGN Study Group, ALIGN Study Group},
title = {Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end‐diastolic umbilical artery flow: international multicenter cohort study},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
volume = {66},
number = {1},
pages = {41--50},
doi = {10.1002/uog.29241}
}
EUVIMED